CORTIFOAM Drug Patent Profile
✉ Email this page to a colleague
When do Cortifoam patents expire, and when can generic versions of Cortifoam launch?
Cortifoam is a drug marketed by Mylan Speciality Lp and is included in one NDA.
The generic ingredient in CORTIFOAM is hydrocortisone acetate. There are sixty-seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydrocortisone acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CORTIFOAM?
- What are the global sales for CORTIFOAM?
- What is Average Wholesale Price for CORTIFOAM?
Summary for CORTIFOAM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 90 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,864 |
| Drug Prices: | Drug price information for CORTIFOAM |
| What excipients (inactive ingredients) are in CORTIFOAM? | CORTIFOAM excipients list |
| DailyMed Link: | CORTIFOAM at DailyMed |
Recent Clinical Trials for CORTIFOAM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| M.D. Anderson Cancer Center | Phase 3 |
| National Cancer Institute (NCI) | Phase 3 |
Pharmacology for CORTIFOAM
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for CORTIFOAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Speciality Lp | CORTIFOAM | hydrocortisone acetate | AEROSOL, METERED;RECTAL | 017351-001 | Feb 10, 1982 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
